SEC Form 4 Reporting Owner · CIK 0001286199
Joseph K Belanoff
CEO at Corcept Therapeutics Inc
Bought (12 mo)
—
Sold (12 mo)
−$10.4M
Form 4 Filings
23
Companies
1
Filing Activity
2026-06-02
first filed 2021-01-26
Trading record
Open-market buys
—
0 filings
Open-market sales
−$38.1M
15 filings
Sales under a 10b5-1 plan
100%
15 of 15 sale filings
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| CORTCorcept Insider trading | CEO | 23 | — | 735,019 | −735,019 | 2,865,489 2026-06-02 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.
Also files as
13D/G Beneficial owner of 5% or more · 1 open stake
| Company | Schedule | % of class | Filed |
|---|---|---|---|
| Corcept | 13G | 6.3% | 2025-02-14 |